Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shares were down 17.1% on Wednesday . The company traded as low as GBX 2.80 and last traded at GBX 2.90. Approximately 8,095,493 shares were traded during trading, an increase of 469% from the average daily volume of 1,422,115 shares. The stock had previously closed at GBX 3.50.
Cizzle Biotechnology Stock Performance
The business’s fifty day simple moving average is GBX 2.74 and its 200 day simple moving average is GBX 2.02. The stock has a market cap of £12.32 million, a price-to-earnings ratio of -17.06 and a beta of 0.02.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last announced its earnings results on Tuesday, May 5th. The company reported GBX (0.17) earnings per share for the quarter.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
See Also
- Five stocks we like better than Cizzle Biotechnology
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
- Insiders Are Selling These 3 Stocks—Should Investors Be Concerned?
- After SpaceX, Amazon Could Be The Next Best Space Stock
- 3 Stocks to Watch If the Strait of Hormuz Reopens
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
